Skip to content

Effect of Ginger and pyridoxin(vitB6) and placebo in the treatment of pica

Effect of Ginger and pyridoxin(vitB6) and placebo in the treatment of first trimester pregnancy_induced nausa and vomiting nausa and vomiting

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015020320923N1
Enrollment
90
Registered
2015-03-11
Start date
2012-09-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nausea and vomiting induced by pregnancy. Vomiting of pregnancy, unspecified

Interventions

Intervention 1: Ginger capsules 500mg for 4days, twice a day. Intervention 2: vit B6 capsules 40mg for 4days, twice a day. Intervention 3: Placebo contain 500mg chickpea pouder for 4days, twice a day.
Treatment - Drugs
Placebo
Ginger capsules 500mg for 4days, twice a day
vit B6 capsules 40mg for 4days, twice a day
Placebo contain 500mg chickpea pouder for 4days, twice a day

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Gestational age 6-16 weeks from LMP OR ultrasound ; Mild to moderate nausea and vomiting induced by pregnancy according to Rhodes index ; Single pregnancy with an alive and healthy fetus ; Without any GI diseases or other organs diseases ; Ability to read and write ; Age 20-35 years ; Not to have any allergy to herbal drugs. Exclusion criteria: Severe nausea and vomiting that needs to be hospitalized; Not to have any tendency to continue use of herbal medicines; Other signs like diarrhea that show nausea and vomiting are pathological; Each disease which makes or increases nausea and vomiting; Allergy to Ginger or pyridoxin.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Duration of nausea. Timepoint: before intervention & 4days after started. Method of measurement: rhodes index (hour).;Frequency of nausea. Timepoint: before intervention & 4days after started. Method of measurement: Rhodes index(number).;Distress from retching. Timepoint: before intervention & 4days after started. Method of measurement: Rhodes index(score).;Frequency of retching. Timepoint: before intervention & 4days after started. Method of measurement: Rhodes index(number).;Vomiting distress. Timepoint: before intervention & 4days after started. Method of measurement: Rhodes index(score).;Amount of vomiting. Timepoint: before intervention & 4days after started. Method of measurement: Rhodes index ( CC).;Distress from nausea. Timepoint: before intervention & 4days after started. Method of measurement: Rhodes index(score).;Frequency of vomiting. Timepoint: before intervention & 4days after started. Method of measurement: Rhodes index (number).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Rezaian

Iran University of Medical Sciences

fatemeh_rezaian@yahoo.com+98 21 4426 0421

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 26, 2026